DE69618614D1 - NUKLEINSÄUREMOLEKÜLE MIT DER FÄHIGKEIT ZUR UNTERSCHEIDUNG VON PrPc UND PrPSc-PRIONPROTEIN-ISOFORMEN UND VERFAHREN ZU DEREN HERSTELLUNG - Google Patents

NUKLEINSÄUREMOLEKÜLE MIT DER FÄHIGKEIT ZUR UNTERSCHEIDUNG VON PrPc UND PrPSc-PRIONPROTEIN-ISOFORMEN UND VERFAHREN ZU DEREN HERSTELLUNG

Info

Publication number
DE69618614D1
DE69618614D1 DE69618614T DE69618614T DE69618614D1 DE 69618614 D1 DE69618614 D1 DE 69618614D1 DE 69618614 T DE69618614 T DE 69618614T DE 69618614 T DE69618614 T DE 69618614T DE 69618614 D1 DE69618614 D1 DE 69618614D1
Authority
DE
Germany
Prior art keywords
nucleic acid
acid molecules
prpsc
prpc
prionprotein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69618614T
Other languages
English (en)
Other versions
DE69618614T2 (de
Inventor
Ernst-Ludwig Winnacker
Stefan Weiss
Michael Famulok
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of DE69618614D1 publication Critical patent/DE69618614D1/de
Publication of DE69618614T2 publication Critical patent/DE69618614T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/115—Aptamers, i.e. nucleic acids binding a target molecule specifically and with high affinity without hybridising therewith ; Nucleic acids binding to non-nucleic acids, e.g. aptamers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6811—Selection methods for production or design of target specific oligonucleotides or binding molecules
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/16—Aptamers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Plant Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE69618614T 1995-10-26 1996-10-25 NUKLEINSÄUREMOLEKÜLE MIT DER FÄHIGKEIT ZUR UNTERSCHEIDUNG VON PrPc UND PrPSc-PRIONPROTEIN-ISOFORMEN UND VERFAHREN ZU DEREN HERSTELLUNG Expired - Fee Related DE69618614T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP95116890 1995-10-26
PCT/EP1996/004671 WO1997015685A1 (en) 1995-10-26 1996-10-25 NUCLEIC ACID MOLECULES CAPABLE OF DISTINGUISHING THE ISOFORMS PrPc AND PrPSc OF PRION PROTEINS AND PROCESSES FOR THEIR PRODUCTION

Publications (2)

Publication Number Publication Date
DE69618614D1 true DE69618614D1 (de) 2002-02-21
DE69618614T2 DE69618614T2 (de) 2002-09-12

Family

ID=8219750

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69618614T Expired - Fee Related DE69618614T2 (de) 1995-10-26 1996-10-25 NUKLEINSÄUREMOLEKÜLE MIT DER FÄHIGKEIT ZUR UNTERSCHEIDUNG VON PrPc UND PrPSc-PRIONPROTEIN-ISOFORMEN UND VERFAHREN ZU DEREN HERSTELLUNG

Country Status (8)

Country Link
US (2) US6426409B1 (de)
EP (1) EP0862653B1 (de)
JP (1) JPH11514874A (de)
AT (1) ATE212065T1 (de)
DE (1) DE69618614T2 (de)
DK (1) DK0862653T3 (de)
ES (1) ES2171231T3 (de)
WO (1) WO1997015685A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002034935A2 (en) * 2000-10-27 2002-05-02 Research Development Foundation In vitro selection of signaling aptamers
DE59805338D1 (de) 1997-09-19 2002-10-02 Evotec Ag Verfahren zur messung der assoziation von teilstrukturen pathologischer proteinablagerungen
DE19916417A1 (de) * 1999-04-01 2000-10-19 Schering Ag Amyloidspezifisches Aptamer
DE19925073C2 (de) * 1999-06-01 2001-07-19 Stefan Weiss Nucleinsäuremoleküle mit spezifischer Erkennung von nativem PrP·S··c·, Herstellung und Verwendung
FR2808278A1 (fr) * 2000-04-28 2001-11-02 Inst Nat Sante Rech Med Proteines a prions et leurs utilisations
GB0012054D0 (en) * 2000-05-18 2000-07-12 Isis Innovation Ligands
WO2002097049A2 (en) * 2001-05-31 2002-12-05 Q-Rna Compositions and methods for binding agglomeration proteins
US20050261486A1 (en) * 2001-05-31 2005-11-24 Q-Rna Compositions and methods for binding agglomeration proteins
US20040005543A1 (en) * 2002-01-18 2004-01-08 Abraham Grossman Compositions and methods for binding agglomeration proteins
US20040096880A1 (en) * 2001-08-07 2004-05-20 Kmiec Eric B. Compositions and methods for the treatment of diseases exhibiting protein misassembly and aggregation
US20040086924A1 (en) * 2001-10-26 2004-05-06 Research Development Foundation In vitro selection of signaling aptamers
WO2003089594A2 (en) * 2002-04-15 2003-10-30 Q-Rna, Inc. A device and methods for concentrating prion protein isoforms
WO2004016644A2 (en) * 2002-08-15 2004-02-26 Q-Rna, Inc. Compositions and methods used for identifying factors required for the agglomeration of proteins
KR101360955B1 (ko) * 2002-09-13 2014-02-10 레플리코르 인코포레이티드 비서열 상보적 항바이러스 올리고뉴클레오티드
US20050196382A1 (en) * 2002-09-13 2005-09-08 Replicor, Inc. Antiviral oligonucleotides targeting viral families
US7399603B2 (en) * 2002-12-19 2008-07-15 Ortho-Clinical Diagnostics, Inc. Antibodies for discrimination of prions
EP1445615A1 (de) * 2003-02-10 2004-08-11 Ortho-Clinical Diagnostics, Inc. Methode zur unterscheidung zwischen infektiösen und nicht-infektiösen prionen
EP1667695A4 (de) * 2003-09-11 2007-01-31 Replicor Inc Oligonucleotide gegen prionen-erkrankungen
US20070123480A1 (en) * 2003-09-11 2007-05-31 Replicor Inc. Oligonucleotides targeting prion diseases

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4917998A (en) * 1986-05-06 1990-04-17 Epitope, Inc. Method of detecting AIDS virus infection
US5270163A (en) * 1990-06-11 1993-12-14 University Research Corporation Methods for identifying nucleic acid ligands
US5567588A (en) * 1990-06-11 1996-10-22 University Research Corporation Systematic evolution of ligands by exponential enrichment: Solution SELEX
US5582981A (en) * 1991-08-14 1996-12-10 Gilead Sciences, Inc. Method for identifying an oligonucleotide aptamer specific for a target
US5573905A (en) * 1992-03-30 1996-11-12 The Scripps Research Institute Encoded combinatorial chemical libraries

Also Published As

Publication number Publication date
DK0862653T3 (da) 2002-03-11
EP0862653A1 (de) 1998-09-09
US6426409B1 (en) 2002-07-30
ES2171231T3 (es) 2002-09-01
WO1997015685A1 (en) 1997-05-01
US20030119019A1 (en) 2003-06-26
JPH11514874A (ja) 1999-12-21
DE69618614T2 (de) 2002-09-12
EP0862653B1 (de) 2002-01-16
ATE212065T1 (de) 2002-02-15

Similar Documents

Publication Publication Date Title
DE69618614T2 (de) NUKLEINSÄUREMOLEKÜLE MIT DER FÄHIGKEIT ZUR UNTERSCHEIDUNG VON PrPc UND PrPSc-PRIONPROTEIN-ISOFORMEN UND VERFAHREN ZU DEREN HERSTELLUNG
DE69942451D1 (de) Methode zum schnellen identifizieren von kleinen organischen liganden
DE60042235D1 (de) Prozess zur trennung von proteinen
ATE328006T1 (de) Neues protein und verfahren zu dessen herstellung
ATE337058T1 (de) Kolonne und mit dieser durchgeführtes chromatographisches verfahren
BR9407047A (pt) Processo para separaçao de uma proteina de uma soluçao aquosa de proteinas
ATE326984T1 (de) Verfahren zur verbindung von molekularen substanzen
ATE90944T1 (de) Fuer ein hirudinaehnliches protein kodierende dns- sequenz und verfahren zur herstellung eines solchen proteins.
ATE135371T1 (de) Mit akuter pankreatitis assoziiertes protein, mittel zur diagnose von akuter pankreatitis
DE60129008D1 (de) Methode zur identifizierung von regulatoren der bildung von protein-age-derivaten
ATE278785T1 (de) Neues verfahren zur gewinnung und reinigung von fusionsproteinen
DE69831500D1 (de) Humane checkpointkinase, hcds1, zusammensetzungen und verfahren
DK0948604T3 (da) Screeningsmetoder for forbindelser som binder til PYK2-polypeptidet
ATE487792T1 (de) Verfahren und zusammensetzungen zur identifikation von rna-bindenden proteinen
ATE417930T1 (de) Proteinkinase npk-110
DE602004032345D1 (de) Reagenzien und verfahren zur bildung von disulfid-bindungen und glykosylierung von proteinen
ATE223491T1 (de) Verfahren zur reinigung von biomolekül- oder proteinkomplexen
WO1999063094A3 (en) Nucleotide and protein sequences of gpr1 and methods based thereon
DE60011785D1 (de) Verfahren zur herstellung von proteinen in wirtszellen unter verwendung von chaperoninen
DE69739880D1 (de) NUKLEINSÄURELIGANDEN MIT HOHER AFFINITÄT FÜR DAS C1q PROTEIN DES KOMPLEMENTSYSTEMS
DE69734890D1 (de) Rdgb-proteine
DE59404414D1 (de) Verfahren zur Abtrennung von L-Leucin und L-Isoleucin aus wässrigen Lösungen
DE59004279D1 (de) Verfahren zur C-terminalen Modifizierung von Proteinen.
DE3853092D1 (de) Verfahren zur Herstellung von Proteinen, die nicht in Proteinen vorkommende Aminosäuren enthalten.
Procopio Proteome Taphonomy: Biomolecular Investigations into the Process of Decay for Forensic and Archaeological Applications

Legal Events

Date Code Title Description
8339 Ceased/non-payment of the annual fee